ILB-2109

N/A

Report date: 2023/07/31 20:00:35
NME

Base Information

Drug NameILB-2109
Drug Alias NameWTS-001ILB-2109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Wutong Tree Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou Wutong Tree Pharmaceutical Co LtdInnolake Biopharm (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A